CP161ZZ
Planar Nuclear Medicine Imaging Pelvis to None with None, Technetium 99m (Tc-99m) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | P Musculoskeletal System |
| Operation | 1 Planar Nuclear Medicine Imaging |
| Body Part | 6 Pelvis |
| Approach | 1 Technetium 99m (Tc-99m) |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions
Procedure Overview
This family describes bone and joint scans in which a radioactive tracer, most often a technetium-99m phosphate compound, is injected and allowed to circulate and concentrate in areas of active bone turnover. A gamma camera then captures a single flat image, or a small series of flat images from fixed positions, showing where the tracer has accumulated across the skeleton. These scans are ordered to find things that plain X-rays can miss early, including stress fractures, bone infection, metastatic spread of cancer to bone, and unexplained bone pain.
Because the images are two-dimensional, planar bone scans are often used as a first-pass, whole-body survey; areas that show unusual tracer uptake can then be studied further with more detailed imaging if needed. The test itself involves an injection followed by a waiting period of a few hours before scanning, and patients are asked to stay still on the imaging table while pictures are taken from front and back.
Anatomy & Axis Detail
Pelvis
Planar imaging of the pelvis targets tracer uptake in the sacrum, iliac bones, pubic and ischial structures, and proximal femora as included in the pelvic field, frequently performed to assess for metastatic disease, insufficiency fractures, or degenerative or inflammatory joint changes involving the hips and sacroiliac joints. The pelvis is a common site for skeletal metastases from prostate and other cancers, so this regional view is often part of a broader oncologic workup even when acquired as a discrete planar study rather than a whole-body scan. Overlapping bowel or bladder activity from tracer excretion can occasionally complicate interpretation, and this should be noted when relevant. Documentation should indicate that the imaging field was limited to the pelvic region to justify this specific body part value.
Radionuclide: Technetium 99m (Tc-99m)
Technetium 99m (Tc-99m) is the most widely used radionuclide in Nuclear Medicine, valued for its short half-life and favorable gamma energy for imaging bone, cardiac, renal, and other organ systems. In this axis position it records that a technetium-based radiopharmaceutical was the tracer administered for the study, distinguishing it from the many other specific isotopes, such as thallium or iodine compounds, used for more specialized indications.
Coding & Documentation
Coders need documentation confirming the images were acquired as discrete flat views rather than as a rotational or tomographic acquisition, since the two are coded from different root operations even when the anatomy and clinical question are identical. The specific musculoskeletal region imaged, or whether the study was a whole-body survey, should be reflected in the body part value chosen. A common error is defaulting to a whole-body code when the report actually describes targeted views of a single joint or limb, or the reverse. Coders should also verify the radiopharmaceutical named in the report matches the qualifier selected, since different agents are used for different clinical questions (for example, bone-seeking phosphates versus agents used to evaluate infection).
Commonly Confused With
The closest source of confusion is Tomographic Nuclear Medicine Imaging of the musculoskeletal system, distinguished purely by whether the report describes flat, fixed-angle images or a rotational SPECT acquisition reconstructed into cross-sections. It can also be confused with Nonimaging Nuclear Medicine Probe studies, which use a handheld detector to count radioactivity at a location rather than produce any picture, and are typically used intraoperatively rather than as a standalone diagnostic scan.